Top Vaccines companies in Japan by Debt to Equity Ratio
Japan
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
0.63
|
March 31, 2024 | USD 9.47 | 0.08% |
|
Japan |
|
| 2 |
0.58
|
Dec. 31, 2023 | USD 12.89 | -3.06% |
|
Japan |
|
| 3 |
0.41
|
March 31, 2024 | USD 3.51 | 6.45% |
|
Japan |
|
| 4 |
0.32
|
March 31, 2024 | USD 0.92 | -1.38% |
|
Japan |
|
| 5 |
0.30
|
March 31, 2024 | USD 0.17 | 0.04% |
|
Japan |
|
| 6 |
0.21
|
Dec. 31, 2023 | USD 3.76 | 2.75% |
|
Japan |
|
| 7 |
0.11
|
March 31, 2024 | USD 9.54 | -0.95% |
|
Japan |
|
| 8 |
0.06
|
Dec. 31, 2023 | USD 2.63 | -0.70% |
|
Japan |
|
| 9 |
0.01
|
March 31, 2024 | USD 14.33 | -1.63% |
|
Japan |
|
| 10 |
0.01
|
March 31, 2024 | USD 24.50 | -0.22% |
|
Japan |
|
| 11 |
0.00
|
March 31, 2024 | USD 11.63 | 0.67% |
|
Japan |
|
| 12 |
0.00
|
Dec. 31, 2023 | USD 9.57 | -3.49% |
|
Japan |
|
| 13 |
0.00
|
June 30, 2024 | USD 1.01 | 1.37% |
|
Japan |
Frequently Asked Questions
-
Which Vaccines company in Japan has the highest Debt to Equity Ratio ?
The Vaccines company in Japan with the highest Debt to Equity Ratio is Astellas Pharma Inc. (Tokyo Stock Exchange: 4503.T) at 0.63.
-
Which Vaccines company in Japan has the lowest Debt to Equity Ratio ?
The Vaccines company in Japan with the lowest Debt to Equity Ratio is Soiken Holdings Inc. (Tokyo Stock Exchange: 2385.T) at 0.00.
-
What are the top 10 Vaccines companies in Japan by Debt to Equity Ratio ?
The top 10 Vaccines companies in Japan by Debt to Equity Ratio are Astellas Pharma Inc., PeptiDream Inc., JCR Pharmaceuticals Co., Ltd., NanoCarrier Co., Ltd., OncoTherapy Science, Inc., Oncolys BioPharma Inc., Santen Pharmaceutical Co., Ltd., RaQualia Pharma Inc., Shionogi & Co., Ltd. and Kissei Pharmaceutical Co., Ltd..
-
What are the bottom 10 Vaccines companies in Japan by Debt to Equity Ratio ?
The bottom 10 Vaccines companies in Japan by Debt to Equity Ratio are Soiken Holdings Inc., Mizuho Medy Co.,Ltd., WDB Holdings Co., Ltd., Kissei Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., RaQualia Pharma Inc., Santen Pharmaceutical Co., Ltd., Oncolys BioPharma Inc., OncoTherapy Science, Inc. and NanoCarrier Co., Ltd..
